drugset / Trial / NCT01366885

Vitamin D to Prevent Autism in Newborn Siblings

NCT01366885

Phase 2 Completed 20 enrolled Oregon Health and Science University
NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to determine whether by administering vitamin D to mothers who already have at least one child with autism and who are pregnant, that the vitamin D will prevent the recurrence of autism in the newborn sibling.

Timeline

Start
2008-02
Primary completion
2016-02
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 400 iu Oral
Subject Cholecalciferol Other / unclassified 1000 iu Oral
Subject Cholecalciferol Other / unclassified 5000 iu Oral
Subject Cholecalciferol Other / unclassified 7000 iu Oral

Indications